CSIMarket
 
Singular Genomics Systems Inc   (NASDAQ: OMIC)
 

Singular Genomics Systems Inc's Customers Performance

OMIC



 
OMIC's Source of Revenues During the corresponding time, Singular Genomics Systems Inc saw a revenue deteriorated by -12.12 % year on year, sequentially revenue fell by -44.91 %. While revenue at the Singular Genomics Systems Inc 's corporate clients

• List of OMIC Customers




for the same period Singular Genomics Systems Inc revnue deteriorated by -12.12 % year on year, sequentially revenue fell by -44.91 %.

• List of OMIC Customers

Singular Genomics Systems Inc's Business Units






Singular Genomics Systems Inc's Comment on Sales, Marketing and Customers



The company plans to launch an early access program by the end of 2024, initially offering an immuno-oncology panel of transcripts and proteins with customizable content. Its PX platform is designed for applications in single-cell analysis, spatial analysis, and proteomics. The G4 product targets the next-generation sequencing (NGS) market, while the G4X Spatial Sequencer is aimed at the spatial biology market, utilizing sequencing technology for transcriptomics, proteomics, and fluorescent H&E imaging in tissue with spatial context. The company collaborated with multiple laboratories and key opinion leaders to develop the G4 product to address practical needs and integrate with existing workflows.





Singular Genomics Systems Inc’s Comment on Sales, Marketing and Customers


The company plans to launch an early access program by the end of 2024, initially offering an immuno-oncology panel of transcripts and proteins with customizable content. Its PX platform is designed for applications in single-cell analysis, spatial analysis, and proteomics. The G4 product targets the next-generation sequencing (NGS) market, while the G4X Spatial Sequencer is aimed at the spatial biology market, utilizing sequencing technology for transcriptomics, proteomics, and fluorescent H&E imaging in tissue with spatial context. The company collaborated with multiple laboratories and key opinion leaders to develop the G4 product to address practical needs and integrate with existing workflows.








OMIC's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Singular Genomics Systems Inc 50.05 2.67 -86.32 190
SUBTOTAL 0.00 0.00 0.00 -

Sources: Singular Genomics Systems Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Singular Genomics Systems Inc’s corporate clients.
For your research, we’ve provided 9 tables on Singular Genomics Systems Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.